Jyoti Palaniappan is VP at Adaptive Biotechnologies Corp (ADPT). They have made 3 open-market trades across 1 company since 2021, most recently 2021-07-19.
CIK 0001807021
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ADPT | 9,158 | $245K |
Shares reported on the most recent Form 4, priced at the 2021-07-19 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ADPT | SELL · 10b5-1 | 2021-07-19 | 2021-07-19 | $36.12 | $24K | -0.6% | -16.6% | -13.1% |
| ADPT | SELL | 2021-06-17 | 2021-06-21 | $39.84 | $130K | -0.0% | -4.3% | -5.4% |
| ADPT | SELL · 10b5-1 | 2021-05-18 | 2021-05-19 | $35.00 | $23K | +5.3% | +13.4% | -12.0% |
| ADPT | SELL | 2021-04-19 | 2021-04-21 | $41.25 | $107K | -10.4% | -14.9% | -10.5% |
| ADPT | SELL | 2021-03-18 | 2021-03-19 | $43.58 | $1.4M | -5.9% | -3.4% | -6.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.